Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody against transforming growth factor beta-1, 2 and 3

EU orphan designation number: EU/3/08/533   
Active ingredient: Recombinant human monoclonal antibody against transforming growth factor beta-1, 2 and 3
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/04/2008 Centralised Orphan - Designation EMEA/OD/105/07 (2008)1299 of 01/04/2008